PLYXPolaryx Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Polaryx Therapeutics, Inc. against Pharmaceutical Preparations — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PLYXThis | $101M#8 | — | 9.3x#13 | — | — | 70.4%#2 | — | -82.1%#10 | — | — | — | — |
| EQ | $120M#1 | — | 2.1x#3 | 2.9x#2 | 13.9%#4 | -177.6%#13 | -57.5%#3 | -40.0%#5 | -368.9%#2 | — | 23.5%#3 | — |
| OKUR | $119M#2 | — | 0.7x#1 | — | — | -13.0%#8 | — | -34.6%#4 | — | — | 21.9%#4 | — |
| PMN | $119M#3 | — | 2.4x#6 | — | — | -1529.3%#16 | — | -80.4%#9 | — | — | 19.9%#5 | — |
| GNLX | $114M#4 | — | 7.1x#12 | 14308.8x#8 | 0.0%#5 | -7.6%#7 | -415175.0%#8 | -199.5%#13 | -424.2%#3 | — | -35.5%#10 | — |
| MIST | $114M#5 | — | 6.3x#10 | — | — | -51.9%#12 | — | -0.3%#1 | — | — | -52.7%#12 | — |
| COYA | $111M#6 | — | 2.6x#7 | 14.0x#4 | 123.6%#1 | -42.6%#11 | -283.9%#4 | -49.0%#6 | — | — | -12.2%#7 | — |
| CPIX | $106M#7 | — | 6.1x#9 | 2.4x#1 | 17.6%#3 | 56.2%#3 | -6.3%#2 | -16.3%#3 | — | — | 114.5%#2 | — |
| CTOR | $96M#9 | — | 2.4x#5 | — | — | -17.1%#10 | — | -61.3%#7 | — | — | -43.0%#11 | — |
| ANIX | $95M#10 | — | 6.6x#11 | 454.4x#6 | 0.0%#5 | 13.0%#5 | -5571.9%#6 | -75.5%#8 | -87.0%#1 | — | -18.5%#9 | — |
| RLYB | $89M#11 | 3.4x#1 | 0.9x#2 | 104.0x#5 | 34.9%#2 | 84.5%#1 | -3853.6%#5 | -9.5%#2 | — | — | 265.6%#1 | — |
| NTHI | $87M#12 | — | — | 2185.7x#7 | -51.8%#8 | -422.3%#15 | -145637.5%#7 | — | — | — | -68.2%#13 | — |
| EMMA | $84M#13 | — | — | 6.8x#3 | -25.2%#7 | -16.1%#9 | 1.9%#1 | — | — | 4#1 | — | — |
| ALDX | $84M#14 | — | 2.2x#4 | — | — | 39.4%#4 | — | -89.3%#11 | — | — | -71.5%#14 | — |
| OSTX | $84M#15 | — | — | — | — | -223.7%#14 | — | — | — | — | -16.5%#8 | — |
| MAIA | $84M#16 | — | 4.1x#8 | — | — | 3.7%#6 | — | -108.3%#12 | — | — | -11.8%#6 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-18.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice